Arbutus Biopharma Corp (ABUS)

CIK 1447028 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Arbutus Biopharma Corp.

Recent SEC filings

FiledFormAccession number
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003716
Oct 22, 20268-K0001171843-26-006753
Oct 7, 202640001447028-26-000059
Oct 7, 202640001447028-26-000061
Oct 7, 202640001447028-26-000058
Oct 7, 2026SCHEDULE 13G/A0000895421-26-000284
Oct 7, 202640001447028-26-000060
Oct 5, 202640001140361-26-038692
Oct 5, 2026SCHEDULE 13D/A0001140361-26-038693
Oct 1, 2026SC TO-I/A0001104659-26-112579
Sep 30, 2026SC TO-I/A0001104659-26-112115
Sep 23, 202640001447028-26-000053
Sep 23, 202640001447028-26-000051
Sep 23, 202640001447028-26-000050
Sep 23, 202640001447028-26-000052
Sep 4, 2026SCHEDULE 13G0000921895-26-002494
Aug 24, 2026SC TO-I0001104659-26-100002
Aug 21, 2026SC TO-C0001104659-26-099391
Aug 21, 20268-K0001104659-26-099390
Aug 12, 202610-Q0001447028-26-000045
Aug 12, 2026SCHEDULE 13G/A0000895421-26-000222
Aug 12, 20268-K0001171843-26-005442
Jul 16, 20268-K0001171843-26-004708
Jun 10, 202640001447028-26-000040
Jun 10, 202640001447028-26-000039